Premium
Approach to the treatment of cutaneous malignancy in HIV‐infected patients
Author(s) -
Wilkins Karl,
Dolev Jacqueline C.,
Turner Ryan,
LeBoit Philip E.,
Berger Timothy G.,
Maurer Toby A.
Publication year - 2005
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1529-8019.2005.05003.x
Subject(s) - medicine , basal cell carcinoma , malignancy , dermatology , human immunodeficiency virus (hiv) , sarcoma , basal cell , melanoma , skin cancer , oncology , pathology , cancer , cancer research , immunology
Patients infected with human immunodeficiency virus (HIV) have an increased risk of developing skin cancers. These at‐risk patients may have atypical presentations and/or altered clinical courses. This article will review and discuss management issues for the following malignancies: lymphomas, malignant melanoma, basal cell carcinoma, squamous cell carcinoma, and Kaposi's sarcoma.